Navigation Links
China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
Date:5/19/2010

30,424 Noncontrolling interest 234,436 215,047 Total Equity 24,071,417 22,045,471 $120,363,054 $120,183,732 CHINA RUITAI INTERNATIONAL HOLDING CO., LTD. AND SUBSIDIARIES Consolidated Statements of Income and Comprehensive Income Three months ended March 31, 2010 2009 (unaudited) (unaudited) Sales $10,238,256 $8,231,180 Cost of sales 6,929,872 4,976,541 Gross profit 3,308,384 3,254,639 Operating expenses: General and administrative expenses 284,252 815,233 Selling expenses 359,075 288,977 Total operating expense 643,327 1,104,210 Commercial leasing income 303,183 -- Cost of commercial leasing (214,007) -- Income from operations 2,754,233 2,150,429 Other income/(expense) Interest income 391,180 542,403 Interest expense (578,487) (765,551) Other income/(expense) 38,295 (41,983) Income before income tax expense 2,605,221 1,885,298 Income tax expense 646,302 471,326 Net income 1,958,919 1,413,972 Less: Net income attributable to the noncontrolling interest 19,389 14,140 Net income attributable to Ch
'/>"/>
SOURCE China Ruitai International Holdings Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. China Sky One Medical Announces First Quarter 2010 Results
2. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
3. China Biologic Products Announces First Quarter 2010 Results
4. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
5. China Sky One Medical to Attend Investment Conferences in May
6. China Biologic Products to Build Two New Plasma Stations in Shandong Province
7. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
8. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
9. China Pharma Holdings, Inc. Announces May Investor Conference Participation
10. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
11. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... NESS ZIONA, Israel , ... today announced that results from a phase I study ... study in advanced Parkinson,s patients, of ND0612, were presented ... Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug ... (SC) delivery patch that would maintain constant levodopa plasma ...
(Date:6/19/2013)... 19, 2013  This year alone, The Leukemia & ... projects with one goal in mind: Discovering lifesaving therapies ... Training" (TNT), a flagship LLS fundraising campaign and the ... marking its landmark 25 th anniversary. To date, ... in research to discover and deliver breakthrough cancer treatments ...
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... events organiser UBM Live , a division of UBM ... CPhI Worldwide and collocated events will be hosted in Madrid, ... for contract and outsourced services and logistics, P-MEC for pharmaceutical ... line-up, InnoPack for pharmaceutical packaging needs. The events will run ...
... 2011 Reportlinker.com announces that a new ... catalogue: Specialty Pharmaceutical Industry ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Specialty Pharmaceutical Industry ... GBI Research,s "Specialty Pharmaceutical ...
Cached Medicine Technology:CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 2CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 3Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 2Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 3Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 4Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 5Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 6Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 7Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 8Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 9Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 10Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 11Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 12Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 13Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 14Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 15Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook 16
(Date:6/19/2013)... 19, 2013 Alternatives, a revolutionary new ... to quit using drugs while allowing them to continue ... founders of Alternatives, believe that abstinence-only approaches force people ... treatment and that this approach hurts instead of helping. ... the United States need treatment for addiction but only ...
(Date:6/19/2013)... Kansas City will host its first Ciclovia event on ... A section of Main Street in the midtown area will be ... event. The Main Street Corridor Development and BikeWalkKC ... City join the ranks of dozens of cities across the US ... community vibrancy and active lifestyles. , “Ciclovia is the perfect event ...
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 19, 2013 ... before physicians deem it medically necessary, according to ... Maternal and Child Health Journal. The results of ... advocating for more than a decade – that ... care, and maintaining a healthy body weight. Fairhaven ...
(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...
(Date:6/19/2013)... today in Menopause International , suggests that ... and less satisfying sex compared to their European ... less likely to access appropriate treatment for a ... first-of-its-kind study, called the CLarifying vaginal atrophy,s impact ... British post-menopausal women with vaginal atrophy are more ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2
... ... Answers Growing Need to Help Safeguard Those with Cognitive,Disorders such as Alzheimer,s and Autism ... Austin, ... embedded and portable surveillance tracking solutions, today announced the launch of a tracking solution ...
... , WASHINGTON , Jan. 27 ... launched "WINHeart -- Score a WIN for Women," an ... diagnosis, treatment and survival of women with cardiovascular disease ... interventional cardiologists within SCAI, today released a new report ...
... severely stressful situations, like those connected to depression and ... in "stress sensitive" brain regions, such as the cingulate ... brain region involved in memory formation. A new ... suggests that chronic insomnia may be another condition associated ...
... new moms, researchers find , WEDNESDAY, Jan. 27 (HealthDay ... cause delayed lactation in new mothers, which means they ... babies, a new study says. , The researchers found ... include such drugs as Prozac and Paxil, may be ...
... ... Leader Provides Payment Platform for Utah’s Answer to Health Care Reform , ... Salt Lake City, UT (Vocus) ... been selected by the State of Utah to provide payment-processing solutions and HSA administration ...
... , Jan. 27 The ... State Department of Children and Families domestic violence lead designated agency ... Jr. , former CEO of United Way of Somerset County ... Hillsborough, New Jersey -based non-profit  501(c)(3) agency. The Bedminster resident,s ...
Cached Medicine News:Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 2Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 3Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 4Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 2Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 3Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 4Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 5Health News:Losing sleep, losing brain? 2Health News:Antidepressants May Complicate Breast-Feeding 2Health News:HealthEquity Partners with State of Utah to Launch Pilot of Utah Health Exchange 2Health News:HealthEquity Partners with State of Utah to Launch Pilot of Utah Health Exchange 3Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 2Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 3Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 4
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... KeraCel Ophthalmic Products are ... formulation of lint-free MEROCEL polyvinyl ... configured to be beneficial to ... being absorbent, and yet firm ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
...
Medicine Products: